Gaithersburg, Maryland — According to state and local development sources, AstraZeneca plans to invest $2,000,000.00 to build out 4,476 square feet of new space in Gaithersburg. The company plans to occupy the new space at 45 W Watkins Mill Rd in Gaithersburg, on or about February 1, 2024. According to the company website We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally. We have three priorities designed to deliver our growth through innovation strategy. Our business is organised to deliver our growth through innovation strategy and achieve our purpose of pushing the boundaries of science to deliver life-changing medicines. Our R&D and Commercial functions promote accelerated decision making and the launches of new medicines across our therapy areas. Inspired by our Values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients, society and our shareholders. We are committed to operating sustainably, in a way that recognises the interconnection between business growth, the needs of society and the limitations of our planet. Our vision for patients is to deliver the healthcare experience and outcomes that people care about most so they can enjoy fulfilling lives. Everything we do is aimed at enhancing the lives of people with disease and illness. Decisions we make across the patient experience are informed by what people tell us matters most to them.

To learn more about AstraZeneca, visit http://www.astrazeneca.com/

Company Contact:
Pascal Soriot, Chief Executive Officer
800-456-3669

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.